CGAS and neoplasm: Our defined PRMT1-cGAS signaling axis might partially explain the synergistic effect of inhibition of PRMT1 and PRMT540, in which both the parallel cGAS and IFI16 signaling might be activated to maximal downstream cascade to trigger anti-tumor immunity.